Evaluation of Serum Beta 2 Microglobulin Levels in Oral Leukoplakia Patients

Journal Title: Journal of Advanced Medical and Dental Sciences Research - Year 2018, Vol 6, Issue 10

Abstract

Background: Oral leukoplakia is defined as a predominantly white lesion or plaque of questionable behavior having excluded, clinically and histopathologically, any other definable white disease or disorderBeta-2 microglobulin is synthesized in all nucleated cells and forms the light chain subunit of the major histocompatibility complex class I antigen. Despite its potential role as a convenient and non-invasive prognostic indicator in malignant lymphomas, the influence of serum β2 microglobulin is currently underestimated, and therapeutic decision making is rarely affected by this marker. Aim of the study: To evaluate serum beta 2 microglobulin levels in oral leukoplakia patients. Materials and methods: The study was conducted in the Department of Oral medicine of the dental institution. The ethical clearance for study protocol was obtained from ethical committee of the institution. For the study, patients who were histopathologically diagnosed as oral leukoplakia wer included. Patients suffering from any allergic, inflammatory, or systemic disease were excluded from the study. A total of 30 patients with confirmed diagnosis of oral leukoplakia were included in the study. For the lab work, 5 ml of venous blood was collected from antecubital vein of all the participating subjects under aseptic conditions. Results: The level of serum beta-2 microglobulin level in patients with hyperkeratosis with mild dysplasia was at 1791.21, in Hyperkeratosis with moderate dysplaisa was at 2093.32, and in Hyperkeratosis with sever dysplasia was at 2269.74. The number of patients with hyperkeratosis with mild dysplaisa was 11, with hyperkeratosis with moderate dysplasia was 13 and with hyperkeratosis with severe dysplasia was 6. Conclusion: From the results of current study, this can be concluded that serum beta-2 microglobulin level can be used as a better indicator and can give an early indication of oral leukoplakia.

Authors and Affiliations

Adil Rasool Malik, Neeraj Grover, Sanjeet Singh, Nishant Singh, Paramjit Singh

Keywords

Related Articles

Assessment of cases of dengue fever by clinical and laboratory findings

Background: Dengue is the most common viral disease in humans. Every year about 50 - 100 million individuals are infected. Dengue is reported in both urban and rural area. The present study was conducted to assess the c...

ASSESSMENT OF RISK FACTORS LEADING TO OBESITY AMONG THE COLLEGE STUDENTS: A COMMUNITY PROGRAMME

Background: Obesity is a disease that affects almost 1/3rd of the adult population. As the pandemic of overweight and obesity around the globe continues to rise, many developing countries face a double burden of over nut...

A STUDY OF PREVALENCE OF CANCER IN FEMALE SEX POPULATION IN REWA REGION (M.P. STATE)

The present study entitled was undertaken to evaluate the incidence and pattern of cancer in female population in Rewa region in Madhya Pradesh State. For this purpose, the records available in the Histopathology Section...

Comparative Evaluation of Plasma Lycopene Levels in Oral Leukoplakia

Background - Leukoplakia is the most common pre-cancerous lesion in the oral cavity. Present study aimed to evaluate plasma lycopene levels in patients with clinically/ histopathologically proven leukoplakia with that of...

Guided tissue regeneration- A review

Guided tissue regeneration typically refers to ridge augmentation or bone regenerative procedures. The present article highlights the importance of guided tissue regeneration in treatment of periodontal diseases.

Download PDF file
  • EP ID EP550068
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Adil Rasool Malik, Neeraj Grover, Sanjeet Singh, Nishant Singh, Paramjit Singh (2018). Evaluation of Serum Beta 2 Microglobulin Levels in Oral Leukoplakia Patients. Journal of Advanced Medical and Dental Sciences Research, 6(10), 150-153. https://europub.co.uk/articles/-A-550068